From the Department of Orthopaedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
J Am Acad Orthop Surg. 2021 Apr 15;29(8):e396-e403. doi: 10.5435/JAAOS-D-19-00793.
A paucity of data exists on safe platelet and international normalized ratio (INR) thresholds for hip fracture surgery. Recent work has called into question the safety of preoperative INRs < 1.5 for total knee arthroplasty, and optimal platelet thresholds are unknown. The purpose of this study was to identify the risk of 30-day postoperative morbidity and mortality in patients with thrombocytopenia or elevated INRs undergoing hip fracture surgery.
The National Surgical Quality Improvement Program database was queried for patients undergoing surgical treatment of a native hip fracture from 2012 to 2017 (N = 86,850). Patient demographic, laboratory, and complication data were collected. Patients with preoperative platelet counts or INRs within one day of surgery were included for analysis. Preoperative platelet counts and INRs were divided into four groups (<50 k/μL, ≥50 k to 100 k/μL, ≥100 k to 150 k/μL, ≥150 k/μL, and ≤1.0, >1.0 to 1.5, >1.5 to 2.0, and >2.0, respectively). Multivariable logistic regressions were used to assess the independent association between platelet count and INR on bleeding complications requiring transfusion, wound complications, reoperations, readmissions, and deaths.
A total of 72,306 and 56,027 patients were included for analysis of preoperative platelet and INR levels, respectively. In reference to platelet levels ≥150 k/μL, a notably increased risk of bleeding events was observed for patients with platelet counts ≥100 k to 150 k/μL (odds ratio [OR] 1.21, 95% confidence interval 1.15 to 1.27), ≥50 to 100 k/μL (OR 1.85, 1.69 to 2.03), and <50 k/μL (OR 1.60, 1.25 to 2.04). Decreasing platelet counts were associated with a stepwise increased risk of mortality from OR 1.12 (1.02 to 1.22) for platelet counts ≥100 k to 150 k/μL to OR 1.63 (1.41 to 1.90) and OR 1.59 (1.06 to 2.39) for platelet counts ≥50 k to 100 k/μL and <50 k/μL, respectively. Elevated INR was associated with an increased risk of reoperations, readmissions, and death (P < 0.001 for all), with largest effect sizes observed starting at INRs >1.5.
The results of this study suggest that preoperative platelet thresholds of <100,000/μL and INR thresholds of 1.5 serve as an important risk factor for complications after hip fracture surgery. Future work is warranted to determine whether preoperative platelet transfusions and/or INR reversal will improve outcomes for these patients.
Prognostic Level III.
关于髋部骨折手术的安全血小板和国际标准化比值(INR)阈值,数据很少。最近的研究对全膝关节置换术术前 INR < 1.5 的安全性提出了质疑,最佳血小板阈值尚不清楚。本研究的目的是确定血小板减少症或 INR 升高的患者在接受髋部骨折手术后 30 天内发生发病率和死亡率的风险。
从 2012 年至 2017 年,国家手术质量改进计划数据库对接受原发性髋部骨折手术治疗的患者进行了查询(N = 86850)。收集患者的人口统计学、实验室和并发症数据。包括术前血小板计数或 INR 在手术前一天内的患者进行分析。术前血小板计数和 INR 分为四组(<50 k/μL、≥50 k 至 100 k/μL、≥100 k 至 150 k/μL、≥150 k/μL 和≤1.0、>1.0 至 1.5、>1.5 至 2.0 和>2.0)。多变量逻辑回归用于评估血小板计数和 INR 与出血并发症(需要输血)、伤口并发症、再次手术、再入院和死亡之间的独立关联。
分别有 72306 名和 56027 名患者被纳入分析术前血小板和 INR 水平。与血小板水平≥150 k/μL 相比,血小板计数≥100 k 至 150 k/μL(比值比[OR] 1.21,95%置信区间 1.15 至 1.27)、≥50 至 100 k/μL(OR 1.85,1.69 至 2.03)和<50 k/μL(OR 1.60,1.25 至 2.04)的患者发生出血事件的风险明显增加。血小板计数逐渐降低与死亡率呈正相关,从血小板计数≥100 k 至 150 k/μL 的 OR 1.12(1.02 至 1.22)到血小板计数≥50 k 至 100 k/μL 的 OR 1.63(1.41 至 1.90)和血小板计数<50 k/μL 的 OR 1.59(1.06 至 2.39)。升高的 INR 与再次手术、再入院和死亡的风险增加相关(所有 P < 0.001),最大的效应大小从 INR >1.5 开始观察到。
本研究结果表明,术前血小板阈值<100000/μL 和 INR 阈值 1.5 是髋部骨折手术后并发症的重要危险因素。需要进一步研究以确定术前血小板输注和/或 INR 逆转是否会改善这些患者的结局。
预后 III 级。